No Data
Vera Therapeutics(VERA.US) Officer Sells US$1.3 Million in Common Stock
$Vera Therapeutics(VERA.US)$ Officer Young Joseph R sold 30,837 shares of common stock on May 15, 16, 2024 at an average price of $42.301 for a total value of $1.3 million.Source: Announcement What is
Vera Therapeutics Insider Sold Shares Worth $1,304,435, According to a Recent SEC Filing
Joseph R Young, Senior Vice President, Finance, Chief Accounting Officer, on May 15, 2024, sold 30,837 shares in Vera Therapeutics (VERA) for $1,304,435. Following the Form 4 filing with the SEC, Youn
Institutional Investors in Vera Therapeutics, Inc. (NASDAQ:VERA) Lost 9.3% Last Week but Have Reaped the Benefits of Longer-term Growth
Key Insights Significantly high institutional ownership implies Vera Therapeutics' stock price is sensitive to their trading actions A total of 9 investors have a majority stake in the company with
Vera Therapeutics | 10-Q: Quarterly report
Vera Therapeutics Is Maintained at Strong Buy by Raymond James
Vera Therapeutics Is Maintained at Strong Buy by Raymond James
Raymond James: Maintaining the Vera Therapeutics (VERA.US) rating, adjusted from strong buy to strong buy rating, and adjusted the target price from $57.00 to $68.00.
Raymond James: Maintaining the Vera Therapeutics (VERA.US) rating, adjusted from strong buy to strong buy rating, and adjusted the target price from $57.00 to $68.00.